AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03984097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Bortezomib subcutaneously.
Study NCT00623766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid: Meprednisone
Description: Participants in the corticosteroid-dependent arm for whom adequate control of metastatic brain lesion-related neurologic signs and symptoms required concurrent corticosteroid therapy with meprednisone
Study NCT00623766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid: Methylprednisolone
Description: Participants in the corticosteroid-dependent arm for whom adequate control of metastatic brain lesion-related neurologic signs and symptoms required concurrent corticosteroid therapy with methylprednisolone
Study NCT00623766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid: Prednisolone
Description: Participants in the corticosteroid-dependent arm for whom adequate control of metastatic brain lesion-related neurologic signs and symptoms required concurrent corticosteroid therapy with prednisolone
Study NCT03984097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide orally.
Study NCT04564729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shared Decision Making
Description: The intervention group will receive a shared decision-making intervention including a decision aid and conversation with a study investigator. The intervention group will have the opportunity to choose the number of opioid pills they receive at discharge from hospital after total knee arthroplasty.
Study NCT00156104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asenapine
Description: 5 mg BID
Study NCT00156104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asenapine
Description: 10 mg BID
Study NCT00156104 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Haloperidol
Description: 4 mg BID
Study NCT00156104 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo arm
Study NCT03880370 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires / scales
Description: EVA, ROLAND MORRIS, OWESTRY and Global Questionnaire of Physical Activity (GPAQ)
Study NCT03880370 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound imaging
Description: Rectus abdominis dominant side \& non-dominant side external oblique dominant side \& non-dominant side internal oblique dominant side \& non-dominant side transversus abdominis dominant side \& non-dominant side lumbar multififidus l4-l5-s1 gluteus medius dominant side \& non-dominant side
Study NCT03880370 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FLEXIBILITY
Description: weight-bearing lunge hip lateral rotation straight leg raise fingertip to floor test
Study NCT03880370 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FUNCTIONAL TESTS
Description: Star excursion balance test (sebt) prone bridging test Side bridging test Modified biering-sørensen
Study NCT02097719 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bimatoprost 0.01%
Description: Bimatoprost 0.01% administered to both eyes once daily for 12 weeks.
Study NCT02097719 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: travoprost 0.004%
Description: Travoprost 0.004% administered to both eyes once daily for 12 weeks.
Study NCT02097719 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: timolol 0.5%
Description: Timolol 0.5% administered to both eyes once daily for 12 weeks.
Study NCT02097719 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hypromellose 0.3%
Description: Hypromellose 0.3% lubricant eye drops (for masking purposes) administered to both eyes once daily for 12 weeks.
Study NCT01039545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac
Description: Diclofenac retard 75mg twice daily for 3 days, followed by fosfomycin 3g single dose on day 4 if deemed necessary
Study NCT01039545 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norfloxacin
Description: Norfloxacin 400mg twice daily for 3 days, followed by fosfomycin 3g single dose on day 4 if deemed necessary
Study NCT02551380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLINORAL
Description: Folinoral (folinic acid) 5mg twice a day (10 mg per day) during 12 weeks
Study NCT02551380 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 5mg twice a day (10 mg per day) during 12 weeks
Study NCT01087359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: 100 mg melatonin is tested on human endotoxaemia administrated on night and day time compared to placebo
Study NCT01943058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: megestrol acetate
Description: Given PO
Study NCT00440219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Prednisone
Description: Prednisone 50 mg once daily for 10 days pre-op
Study NCT00440219 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator
Description: Placebo pill identical to Prednisone 10 days once daily pre-op
Study NCT03233503 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Basic taste, fat sensation and texture perception
Description: This is an observational Sensory study methodologically similar to Astringency and bitterness perception clinicalTrials.gov identifier NCT03171402 Participants are first involved in sensory training sessions that train how they recognise between different basic tastes and differentiate perceived intensity in solutions and foods. After 6 months of training, the trained participants are involved in tasting a wide array of commonly consumed foods. At this study phase, participants will rate for the foods' taste, fat sensation perception and texture
Study NCT01943058 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: levonorgestrel-releasing intrauterine system
Description: Given IUD
Study NCT01943058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01943058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Ancillary studies
Study NCT02933424 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein Powder
Study NCT01786044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MasterMed
Description: An online interactive educational program
Study NCT01786044 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Study NCT01929434 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rehabilitation
Description: Patients only receive rehabilitation of physical therapy and occupational therapy.
Study NCT01929434 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: stem cell injection
Description: Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
Study NCT03856164 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid
Description: Two doses of Tranexamic Acid (1 gram), diluted in 100 cc of normal saline. Administered intravenously at least 10 minutes prior to skin incision and repeated immediately after placental delivery.
Study NCT03856164 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100 mL of normal saline. Administered intravenously at least 10 minutes prior to skin incision and repeated immediately after placental delivery.
Study NCT00089154 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: apolizumab
Description: Given IV
Study NCT00089154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT00623766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid: Prednisone
Description: Participants in the corticosteroid-dependent arm for whom adequate control of metastatic brain lesion-related neurologic signs and symptoms required concurrent corticosteroid therapy with prednisone
Study NCT02202915 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Checklist
Study NCT03657784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: P03277
Description: Single intravenous bolus injection at 0.1 mmol/kg body weight at a rate of 2 mL/second
Study NCT03909906 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euphytose®
Description: (50mg Valeriana officinalis L., 40mg Passiflora incarnate L., 10mg Crataegus sp., 10mg Ballota nigra L.)
Study NCT03909906 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo comparator
Study NCT04979026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active ankle pumping with a regular watch alarm
Description: In addition to the active ankle pumping exercise for the operative limb, the patients were reminded to exercise at specific time points with a vocal alarm and vibration through a wrist watch during the hospitalization period and at home after discharge.
Study NCT04979026 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intermittent pneumatic compression
Description: In this group, intermittent pneumatic compression was applied to the operative low limb during hospitalization, while active ankle pumping exercise was adopted without any reminder after discharge.
Study NCT02569424 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient's position
Description: Supine or Trendelenburg strict -20°)
Study NCT03254706 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Peak etch-and-rinse (P1)
Description: Application Mode - Peak Adhesive system applied according to the manufacturer's instructions.
Study NCT03254706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peak applied for double time(P2X)
Description: Application Mode - Peak Adhesive system applied according to the manufacturer's instructions, but for the double time.
Study NCT03254706 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Single Link etch-and-rinse (SL1)
Description: Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions.
Study NCT03254706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single Link double time (SL2X)
Description: Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions, but for the double time.
Study NCT00623766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid: Triamcinolone
Description: Participants in the corticosteroid-dependent arm for whom adequate control of metastatic brain lesion-related neurologic signs and symptoms required concurrent corticosteroid therapy with triamcinolone
Study NCT04202432 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Mean systemic filling pressure
Description: Peri- and postoperative measurement of continuous cardiac output with thermodilution derived pulse contour calculated device (PiCCO).~Estimation of mean systemic filling pressure using a computerized algorithm and by creating venous return curves with inspiratory hold maneuvers, thereby extrapolating the VR-curve until mean systemic filling pressure is calculated.
Study NCT02387073 — intervention group
Intervention type: OTHER
Intervention: Electrical version patient reported outcome questionnaire
Description: Assess satisfaction of patients with electrical version patient reported outcome questionnaire.
Study NCT02159365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elotuzumab
Study NCT02159365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Study NCT03042429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cycles N8, N5 and N6
Description: two chemotherapy cycles N8 followed by standard arm therapy
Study NCT03042429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cycles N5 and N6
Description: Standard arm six chemotherapy cycles (3xN5 and 3x N6) followed by myeloablative therapy with stem cell support and isotretinoin
Study NCT02816268 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pulmonary vein isolation
Study NCT03349138 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Study NCT03349138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Glove
Study NCT03349138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation
Study NCT03877614 — intervention group
Intervention type: OTHER
Intervention: ASCVD risk score
Description: ASCVD score\< 10% will be in the control or low-risk group
Study NCT00543270 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powerlink infrarenal bifurcated stent graft delivery system
Description: Endovascular abdominal aortic aneurysm repair
Study NCT02159365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Study NCT00543270 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Surgery
Description: Open surgical abdominal aortic aneurysm repair
Study NCT01652053 — intervention group
Intervention type: DEVICE
Intervention: Disc Nucleus Replacement (InterCushion DNP)
Description: The device is intended for spinal arthroplasty in skeletally mature patients with leg pain due to a herniated disc with or without back pain, who are having a discectomy at one level from L2 -S1. These patients should have no spondylolisthesis at the involved level.
Study NCT04236050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium
Description: Rocuronium administered in continuous infusion or multiple bolus doses
Study NCT04236050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium
Description: Rocuronium administered in continuous infusion or multiple bolus doses
Study NCT04437550 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: high intensity exercise = 15 x 60 s sprints at 85% velocity of VO2max (vVO2max) with 60 s walking at 20% vVO2max or moderate intensity exercise = walking at 60% vVO2max
Study NCT00089154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT02774525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reinforcement for drug & alcohol abstinence
Study NCT02774525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting intervention
Study NCT02774525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting
Study NCT02774525 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting
Study NCT00796549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BiBW 2992
Description: BIBW 2992 in EGFR FISH positive NSCLC patients
Study NCT01102946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Description: Ranibizumab (Lucentis), intravitreal injections of 0.05ml
Study NCT01102946 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Panretinal Photocoagulation
Description: Panretinal photocoagulation with green laser according to ETDRS
Study NCT01102946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Panretinal Photocoagulation
Description: Panretinal photocoagulation with green laser according to ETDRS
Study NCT02661256 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NCPAP
Description: Does NCPAP induce dysphagia in neonates? Each baby will be evaluated for dysphagia (using fluoroscopy) while on NCPAP and off NCPAP.
Study NCT02661256 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Varibar® Thin Liquid Barium Sulfate for Suspension
Description: Liquid barium is used as a contrast material to allow visualization of swallowed boluses under fluoroscopy.
Study NCT04143490 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: 60 minutes of continuous exercise at 65% VO2peak and drink ingestion
Study NCT04143490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 60 minutes of continuous exercise at 65% VO2peak and drink ingestion
Study NCT05877937 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supportive care (Watching a comedy movie)
Description: A 10.1 inch Android tablet (2 pieces) and disposable earplugs for each patient were used in the study. A comic film archive was created in line with the recommendation and consultancy of department of state conservatory and performing arts. In this regard, the officials of the Conservatory stated that they had no standardized comedy films specific to society and emphasized that the standardization of art limits art activities. Therefore, there should be no limitations for art. In the film archive cre-ated according to their suggestions, there were a total of five comedy movies, including three Turkish comedies, one foreign romantic comedy, and one foreign Turkish-dubbed family comedy. The original/licensed versions of the movies in this archive were ob-tained and uploaded to the tablet. The movies lasted 90-120 minutes (as long as the av-erage duration of IV treatment). The patients selected the movie that they would watch during the treatment.
Study NCT01949571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirtazapine (REMERON, Schering-Plough-Organon)
Description: During the first and second phase of the study,the mirtazapine group received 30 mg of mirtazapine daily. During the third phase, the mirtazapine group received 15 mg of mirtazapine.
Study NCT01159678 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online psychoeducation
Description: The online psychoeducation contains 12 modules which will be administered once per week over the course of three months. The content of each module is as follows:~1. Important of sexuality to quality of life. \& Definitions of sexual desire and arousal.~2. Consideration of the predisposing, precipitating, and perpetuating factors in his/her sexual difficulties.~3. Sexual beliefs.~4. Mindfulness.~5. Genital anatomy and physiology.~6. Body Image.~7. Relationship satisfaction and communication.~8. Body-oriented mindfulness exercises (focusing and self-observation).~9. Using Thought records.~10. Mindfulness and the thought stream.~11. Sexual aids to boost arousal.~12. Moving on.~In addition to these weekly modules, all participants will have access to a moderated and password-protected bulletin board to which participants can post questions and the PI will respond.
Study NCT02597452 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: intelligent Breast Exam, iBE
Description: A bilateral iBE exam will be performed on the entire breast in addition to a clinical breast exam administered by a trained individual. If the patient is selected to participate in the inter-rater reliability portion of the study, the subject will undergo both the iBE and the clinical breast exams twice sequentially performed by two different separately trained individuals during the same visit.
Study NCT01555970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Description: Week 1: 1200 mg (one 600 mg capsule twice a day) Week 2: 2400 mg (two 600 mg capsules twice a day) Weeks 3-16: 3000 mg (two 600 mg capsules in the morning and 3 in the evening)
Study NCT01555970 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Week 1: one capsule twice a day Week 2: two capsules twice a day Weeks 3-16: two capsules in the morning and 3 in the evening
Study NCT02400606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Constructing VP cases
Description: The participants were presented with a short case overview. The control group solved the cases, whereas the intervention group also received the final diagnosis and had to complete the history, physical findings, and lab results. After a week, participants completed a transfer test involving two standardized patients presenting a respiratory case and a cardiology case, respectively. Performances were video-recorded and subsequently assessed by two blinded raters using the Reporter-Interpreter- Manager-Educator (RIME) framework. Knowledge gains were assessed using a pre- and post-test of a 95-item Multiple-Response-Questionnaire (MRQ).
Study NCT02400606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Solving VP cases
Description: See above
Study NCT02052115 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: 12 month exercise and weight loss intervention
Study NCT01010490 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Torsional ultrasound (INFINITI, Alcon, USA)
Description: Comparison of inta-operative efficacy and safety
Study NCT04511091 — intervention group
Intervention type: PROCEDURE
Intervention: VATS lobectomy
Description: VATS lobectomy allows surgeons to carry out exactly the same operation within the chest that is performed by thoracotomy, but it is done through 3-4 small incisions without rib spreading rather than the large incision with rib spreading that a thoracotomy entails. The surgeon gains his view inside the chest from a small video camera inserted through one of the small incisions, and the procedure is carried out with long instruments passed through the other small incisions.
Study NCT01522196 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varespladib
Description: 48 hour continuous infusion delivered intravenously (IV)at a rate of 110µg/kg/hr.